Bullish Case: INOD rebounded +30.5% off the $55 lows to $71.85 and the Helium density peaks near $70–72 with a fat right tail toward $75+. Call flow runs 60% above puts, bullish risk exceeds bearish by 33%, and Helium's term structure (~44–60% near-dated IV vs market ~82%) suggests market downside fear is overpriced. FY2025 grew revenue 47.6% with real profits — a continued AI backlog conversion can re-rate shares toward $80–90.

Bearish Case: P/B of 6.7 and ~7.6x sales leave little cushion if Meta-linked AI revenue proves cyclical or in-housed. One customer still drives ~37–58% of revenue, a securities class action is pending, and market IV (~82–99%) prices a genuine downside tail. A guidance miss or SPY risk-off could quickly erase the month's +30% bounce back toward the low $60s.

Potential Outcomes:

1. 40%: Rangebound $64–$78 into late Oct (flat Helium term structure, low option volume percentile).
2. 25%: +12–25% push toward $80–90 on new AI/enterprise contract wins (call-heavy flow supports this).
3. 20%: -15–30% retrace to $50–$61 on concentration/legal headlines or SPY drawdown (market put skew and $55 memory).
4. 10%: IV spike >110% with <8% price move (event-vol pattern seen repeatedly in prior cycles).
5. 5%: Strategic deal/Meta confirmation gap >+35% toward $95–100.

Oracle: with Helium near-term IV ~40 pts below market, selling rich near-dated premium (e.g., Oct 30 82/85 calls) while owning small longer-dated downside protection offers favorable vol spread; reassess around Oct 9/16 expiries.

October 03, 2026